QPBE
Quintet Private Bank (Europe) Portfolio holdings
AUM
$1.73B
1-Year Return
18.27%
This Quarter Return
-3.1%
1 Year Return
+18.27%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$1.5B
AUM Growth
-$583M
(-28%)
Cap. Flow
-$524M
Cap. Flow
% of AUM
-35.05%
Top 10 Holdings %
Top 10 Hldgs %
51.35%
Holding
287
New
35
Increased
85
Reduced
113
Closed
49
Top Buys
| 1 |
Otis Worldwide
OTIS
|
+$18.4M |
| 2 |
Fortive
FTV
|
+$13.6M |
| 3 |
CME Group
CME
|
+$4.67M |
| 4 |
SolarEdge
SEDG
|
+$2.67M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$2.55M |
Top Sells
| 1 |
Apple
AAPL
|
+$141M |
| 2 |
Amazon
AMZN
|
+$102M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$88.5M |
| 4 |
Blackrock
BLK
|
+$43.3M |
| 5 |
Edwards Lifesciences
EW
|
+$41.5M |
Sector Composition
| 1 | Technology | 32.26% |
| 2 | Healthcare | 14.57% |
| 3 | Communication Services | 14.08% |
| 4 | Financials | 12.73% |
| 5 | Consumer Discretionary | 9.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
176
Oracle
ORCL
$678B
| $30.3K | ﹤0.01% |
286
-334
| -54% | -$35.4K |
|
177
GE HealthCare
GEHC
$35.9B
| $29.9K | ﹤0.01% |
440
-3
| -0.7% | -$204 |
|
178
Apellis Pharmaceuticals
APLS
$3.39B
| $28.6K | ﹤0.01% |
752
-13
| -2% | -$495 |
|
179
Day One Biopharmaceuticals
DAWN
$759M
| $28.4K | ﹤0.01% |
2,313
+11
| +0.5% | +$135 |
|
180
MetLife
MET
$52.7B
| $28.1K | ﹤0.01% |
+447
| New | +$28.1K |
|
181
Ingersoll Rand
IR
$31.7B
| $28K | ﹤0.01% |
+439
| New | +$28K |
|
182
Huntsman Corp
HUN
$1.95B
| $24.4K | ﹤0.01% |
1,000
+24
| +2% | +$586 |
|
183
IHS Holding
IHS
$2.42B
| $24.1K | ﹤0.01% |
4,350
+190
| +5% | +$1.06K |
|
184
General Dynamics
GD
$86.4B
| $22.1K | ﹤0.01% |
100
+1
| +1% | +$221 |
|
185
Coherent
COHR
$15.5B
| $21.8K | ﹤0.01% |
+668
| New | +$21.8K |
|
186
CVS Health
CVS
$91B
| $21.6K | ﹤0.01% |
309
+4
| +1% | +$279 |
|
|
XIFR
187
XPLR Infrastructure, LP
XIFR
$930M
| $20.8K | ﹤0.01% |
+700
| New | +$20.8K |
|
188
Inspire Medical Systems
INSP
$2.41B
| $19.8K | ﹤0.01% |
100
-1
| -1% | -$198 |
|
189
Chewy
CHWY
$17.4B
| $18.3K | ﹤0.01% |
1,000
-24
| -2% | -$438 |
|
190
Exact Sciences
EXAS
$10.5B
| $17.3K | ﹤0.01% |
254
-83
| -25% | -$5.66K |
|
191
Jackson Financial
JXN
$6.72B
| $16.3K | ﹤0.01% |
+427
| New | +$16.3K |
|
192
iShares Select Dividend ETF
DVY
$20.7B
| $16.1K | ﹤0.01% |
150
+51
| +52% | +$5.49K |
|
193
iShares S&P 500 Value ETF
IVE
$41B
| $15.4K | ﹤0.01% |
100
-48
| -32% | -$7.38K |
|
194
XPeng
XPEV
$19.7B
| $14K | ﹤0.01% |
765
+433
| +130% | +$7.95K |
|
195
Teladoc Health
TDOC
$1.38B
| $13.3K | ﹤0.01% |
718
+457
| +175% | +$8.5K |
|
196
Organon & Co
OGN
$2.7B
| $12.6K | ﹤0.01% |
+726
| New | +$12.6K |
|
197
Verizon
VZ
$184B
| $12.4K | ﹤0.01% |
382
-7,987
| -95% | -$259K |
|
198
iShares S&P 500 Growth ETF
IVW
$64.3B
| $12K | ﹤0.01% |
175
-541
| -76% | -$37K |
|
199
Boston Scientific
BSX
$160B
| $10.6K | ﹤0.01% |
200
-1
| -0.5% | -$53 |
|
200
Macy's
M
$4.61B
| $10.4K | ﹤0.01% |
900
+27
| +3% | +$313 |
|